Thomas O. Daniel - 01 Jun 2021 Form 4 Insider Report for Magenta Therapeutics, Inc. (DNTH)

Role
Director
Signature
/s/ Cindy Driscoll, Attorney-in-Fact for Thomas O. Daniel
Issuer symbol
DNTH
Transactions as of
01 Jun 2021
Net transactions value
$0
Form type
4
Filing time
03 Jun 2021, 18:30:51 UTC
Previous filing
17 May 2021
Next filing
10 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGTA Stock Option (Right to Buy) Award $0 +18,188 $0.000000 18,188 01 Jun 2021 Common Stock 18,188 $12.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable in full upon the earlier to occur of (a) June 1, 2022 or (b) the next annual meeting of the Issuer's stockholders.